References
Abelson, HT, Rabstein, LS (1970) Lymphosarcoma: virus-induced thymic-independent disease in mice. Cancer Res 30: 2213–2222
Baikie, AG, Court Brown, WM, Buckton, KE, Harnden, DG, Jacobs, PA, Tough, IM (1960) A possible specific chromosome abnormality in human chronic myeloid leukaemia. Nature 188: 1165–1166
Bartram, CR, deKlein, A, Hagemeijer, A, vanAgthoven, T, vanKessell, AG, Bootsma, D, Grosveld, G, Ferguson-Smith, MA, Davies, T, Stone, M, Heisterkamp, N, Stephenson, JR, Groffen, J (1983) Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 306: 277–280
Bartram, CR, Kleihauer, E, deKlein, A, Grosveld, G, Teyssier, JR, Heisterkamp, N, Groffen, J (1985) C-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J 4: 683–686
Ben-Neriah, Y, Daley, GQ, Mes-Masson, A, Witte, ON, Baltimore, D (1986) The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233: 212–214
Berger, R, Chen, SJ, Chen, Z (1990) Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects. Cancer Genet Cytogenet 44: 143–152
Bernards, A, Rubin, CM, Westbrook, CA, Paskind, M, Baltimore, D (1987) The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic mylogenous leukemia. Mol Cell Biol 7: 3231–3236
Boveri, T (1912) Beitrag zum Studium des Chromatins in den Epithelzellen der Carcinome. Beitr Pathol 14: 249
Canaani, E, Steiner-Saltz, D, Aghai, E, Gale, RP, Berrebi, A, Januszewicz, E (1984) Altered transcription of an oncogene in chronic myeloid leukemia. Lancet I: 593–595
Caspersson, T, Zech, L, Johanssen, C (1970) Differential binding of alkylating fluorochromes in human chromosomes. Exp Cell Res 60: 315–319
Chan, LC, Karhi, KK, Rayter, SI, Heisterkamp, N, Eridani, S, Powles, R, Lawler, SD, Groffen, J, Foulkes, JG, Greaves, MF, Wiedemann, LM (1987) A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia. Nature 325: 635–637
Chen, SJ, Flandrin, G, Daniel, M-T, Valensi, F, Baranger, L, Grausz, D, Bernheim, A, Chen, Z, Sigaux, F, Berger, R (1988) Philadelphia-positive acute leukemia: lineage promisculty and inconstently rearranged breakpoint cluster region. Leukemia 2: 261–273
Chen, SJ, Chen, Z, Font, M-P, d'Auriol, L, Larsen, C-J, Berger, R (1989a) Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemia with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation. Nucleic Acids Res 17: 7631–7642
Chen, SJ, Chen, Z, d'Auriol, L, LeConiat, M, Grausz, D, Berger, R (1989b) Ph1+bcr — acute leukemias: implication of Alu sequences in a chromosomal translocation occurring within the BCR gene. Oncogene 4: 195–202
Clark, SS, McLaughlin, J, Crist, WM, Champlin, R, Witte, ON (1987) Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science 235: 85–88
Clark, SS, McLaughlin, J, Timmons, M, Pendergast, AM, Ben-Neriah, Y, Dow, LW, Crist, W, Rovera, G, Smith, SD, Witte, ON (1988) Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 239: 775–777
Collins, SJ, Kubonishi, J, Miyoshi, J, Groudine, MT (1984) Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells. Science 225: 72–74
Collins, SJ, Coleman, H, Groudine, MT (1987) Expression of bcr and bcr/abl fusion transcripts in normal and leukemic cells. Mol Cell Biol 7: 2870–2876
Cook, WD, Metcalf, D, Nicola, NA, Burgess, AW, Walker, F (1985) Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 41: 677–683
Court Brown, WM, Abbatt, JD (1955) The incidence of leukaemia in ankylosing spondylitis treated with X-rays. A preliminary report. Lancet I: 1283
Crist, W, Carroll, A, Shuster, J, Jackson, J, Head, D, Borowitz, M, Behm, F, Link, M, Steuber, P, Ragab, A, Hirt, A, Brock, B, Land, V, Pullen, J (1990) Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A pediatric oncology group study. Blood 76: 4892–4894
Daley, GQ, Baltimore, D (1988) Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210bcr/abl protein. Proc Natl Acad Sci USA 85: 9312–9316
Daley, GQ, McLaughlin, J, Witte, ON, Baltimore, D (1987) The CML-specific p210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 237: 532–535
Daley, GQ, VanEtten, RA, Baltimore, D (1990) Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 247: 824–830
DeBraekeleer, M (1987) Variant Philadelphia translocations in chronic myeloid leukemia. Cytogenet Cell Genet 44: 215–222
DeKlein, A (1987) Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia. Mutat Res 186: 161–172
DeKlein, A, vanKessel, AG, Grosveld, G, Bartram, CR, Hagemeijer, A Bootsma, D, Spurr, NK, Heisterkamp, N, Groffen, J, Stephenson, JR (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 300: 765–767
DeKlein, A, Hagemeijer, A, Bartram, CR, Houwen, R, Hoefsloot, L, Carbonell, F, Chan, L, Barnett, M, Greaves, M, Kleihauer, E, Heisterkamp, N, Groffen, J, Grosveld, G (1986) bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood 68: 1369–1375
Dhut, S, Dorey, EL, Horton, MA, Garnesan, TS, Young, BD (1988) Identification of two normal bcr gene products in the cytoplasm. Oncogene 3: 561–566
Dobrovic, A, Trainor, K, Morley, AA (1988) Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction. Blood 72: 2063–2065
Dobrovic, A, Morley, AA, Seshadri, R, Januszewicz, EH (1991) Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML. Leukemia 5: 187–190
Eisenberg, A, Silver, R, Soper, L, Arlin, Z, Coleman, M, Bernhardt, B, Benn, P (1988) The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia. Leukemia 2: 642–647
Elefanty, AG, Hariharan, IK, Cory, S (1990) bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J 9: 1069–1078
Erikson, J, Griffin, CA, ar-Rushdi, A, Valtieri, M, Hoxie, J, Finan, J, Emanuel, BS, Rovera, G, Nowell, PC, Croce, CM (1986) Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic-leukemia. Proc Natl Acad Sci USA 83: 1807–1811
Fainstein, E, Marcelle, C, Rosner, A, Canaani, E, Gale, RP, Dreazen, O, Smith, SD, Croce, CM (1987) A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330: 386–388
Fialkow, PJ, Jacobson, RJ, Papayannopoulou, T (1977) Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage Am J Med 63: 125–130
Gale, RP, Butturini, A (1990) Ph — chromosome positive acute leukemias and acute phase CML: one or two diseases? Two. Leuk Res 14: 295–297
Gale, RP, Canaani, E (1984) An 8-kilobase abl RNA transcript in chronic myelogenous leukemia. Proc Natl Acad Sci USA 81: 5648–5652
Geurts Van Kessel, AHM (1982) Decreased tumorigenicity of Chinese hamster cells after fusion with tumorigenic mouse myeloid leukemia cells. Cytogenet Cell Genet 34: 253–256
Goff, SP, Gilboa, E, Witte, ON, Baltimore, D (1980) Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell 22: 777–785
Groffen, J, Stephenson, JR, Heisterkamp, N, deKlein, A, Bartram, CR, Grosveld, G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36: 93–99
Grossman, A, Silver, RT, Arlin, Z, Coleman, M, Camposano, E, Gascon, P, Benn, PA (1989) Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia. Am J Hum Genet 45: 729–738
Gunz, FW, Henderson, ES (1983) Leukemia, 4th edn. Grune & Stratton, New York, p 986
Hagemeijer, A, Bartram, CR, Smit, EME, vanAgthoven, AJ, Bootsma, D (1984) Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation? Cancer Genet Cytogenet 13: 1–16
Hagemeijer, A, deKlein, A, Godde-Salz, E, Turc-Carel, C, Smit, EME, vanAgthoven, AJ, Grosveld, GC (1985) Translocation of c-abl to “masked” Ph in chronic myeloid leukemia. Cancer Genet Cytogenet 18: 95–104
Hariharan, IK, Adams, JM (1990) cDNA sequence for human bcr, the gene that translocate to the abl oncogene in chronic myeloid leukemia. EMBO J 6: 115–119
Hariharan, IK, Adams, JM, Cory, S (1988) bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res 3: 387–399
Hariaharan, IK, Harris, AW, Crawford, M, Abud, H, Webb, E, Cory, S, Adams, JM (1989) A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9: 2798–2805
Hauschka, TS (1953) Cell population studies on mouse ascites tumours. Transactions NY Acad Sci Ser II 16: 64–73
Hayata, I, Kakati, S, Sandberg, AA (1973) A new translocation related to the Philadelphia chromosome. Lancet II: 1385
Heim, S, Mitelman, F (1987) Cancer cytogenetics. Liss, New York, p 309
Heisterkamp, N, Groffen, J, Stephenson, JR, Spurr, NK, Goodfellow, PN, Solomon, E, Carritt, B, Bodmer, WF (1982) Chromosomal localisation of human cellular homologues of two viral oncogenes. Nature 299: 747–749
Heisterkamp, N, Stephenson, JR, Groffen, J, Hansen, PF, deKlein, A, Bartram, CR, Grosveld, G (1983) Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306: 239–242
Heisterkamp, N, Stam, K, Groffen, J, deKlein, A, Grosveld, G (1985) Structural organization of the bcr gene and its role in the Ph1 translocation. Nature 315: 758–761
Heisterkamp, N, Jenster, G, tenHoeve, J, Zovich, D, Pattengale, PK, Groffen, J (1990) Acute leukaemia in bcr/abl transgenic mice. Nature 344: 251–253
Hermans, A, Heisterkamp, N, vonLindern, M, vanBaal, S, Meijer, D, van derPlas, D, Wiedemann, LM, Groffen, J, Bootsma, D, Grosveld, G (1987) Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51: 33–40
Hermans, A, Gow, J, Selleri, L, vonLindern, M, Hagemeijer, A, Wiedemann, LM, Grosveld, G (1988) bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 2: 628–633
ISCN (1985) An international system for human cytogenetic nomenclature: birth defects. Original article series, vol 21. The National Foundation, New York
Kawasaki, ES, Clark, SS, Coyne, MY, Smith, SD, Champlin, R, Witte, ON, McCormick, FP (1988) Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85: 5698–5702
Kelliher, MA, McLaughlin, J, Witte, ON, Rosenberg, N (1990) Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 87: 6649–6653
Kloetzer, W, Kurzrock, R, Smith, L, Talpaz, M, Spiller, M, Gutterman, JU, Arlinghaus, R (1985) The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Virology 140: 230–238
Konopka, JB, Witte, ON (1985) Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol Cell Biol 5: 3116–3123
Konopka, JB, Watanabe, SM, Witte, ON (1984) An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37: 1035–1042
Kurzrock, R, Shtalrid, M, Romero, P, Kloetzer, WS, Talpaz, M, Trujillo, JM, Blick, M, Beran, M, Gutterman, JU (1987a) A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 325: 631–635
Kurzrock, R, Shtalrid, M, Talpaz, M, Kloetzer, WS, Gutterman, JU (1987b) Expression of c-abl in Philadelphia-positive acute myelogenous leukemia. Blood 70: 1584–1588
Lange, RD, Moloney, WC, Yamawaki, T (1954) Leukemia in atomic bomb survivors. I General observations. Blood 15: 313
Lee, M-S, Chang, K-S, Cabanillas, F, Freireich, EJ, Trujillo, JM, Stass, SA (1987) Detection of minimal residual cells carrying the t(14; 18) by DNA sequence amplification. Science 237: 175–178
Levan, A (1956) Chromosome studies on some human tumors and tissues of normal origin grown in vivo and in vitro at the Sloan-Kettering Institute. Cancer 9: 648–663
Li, W, Dreazen, O, Kloetzer, W, Gale, RP, Arlinghaus, RB (1989) Characterization of bcr gene products in hematopoietic cells. Oncogene 4: 127–138
Lifshitz, B, Fainstein, E, Marcelle, C, Shtivelman, E, Amson, R, Gale, RP, Canaani, E (1988) bcr genes and transcripts. Oncogene 2: 113–117
Lugo, TG, Witte, ON (1989) The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc. Mol Cell Biol 9: 1263–1269
Lugo, TG, Pendergast, A, Muller, AJ, Witte, ON (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247: 1079–1082
Makino, S (1954) Further evidence favouring the concept of the stern cell in ascites tumors of rats. Ann NY Acad Sci Ser II 16: 818–830
McLaughlin, J, Chianese, W, Witte, ON (1987) In vitro transformation of immature hematopoietic cells by the p210 bcr/abl oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci USA 84: 6558–6562
McLaughlin, J, Chianese, E, Witte, ON (1989) Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol 9: 1866–1874
Metcalf, D, Moore, MAS, Sheridan, JW, Spitzer, G (1974) Responsiveness of human granulocytic leukemic cells to colony-stimulating factor. Blood 43: 847–859
Morris, CM, Reeve, AE, Fitzgerald, PH, Hollings, PE, Beard, MEJ, Heaton, DC (1986) Genomic diversity correlates with clinical variation in Ph1-negative chronic myeloid leukaemia. Nature 320: 281–283
Nowell, PC, Hungerford, DA (1960) A minute chromosome in human chronic granulocytic leukemia. Science 132: 1497
Oliff, A, Agranowsky, O, McKinney, MD, Murty, VVVS, Banchwitz, R (1985) Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenec cell lines by Abelson leukemia virus. Proc Natl Acad Sci USA 82: 3306–3310
Prakash, O, Yunis, JJ (1984) High resolution chromosomes of the t(9; 22) positive leukemias. Cancer Genet Cytogenet 11: 361–367
Pugh, WC, Pearson, M, Vardiman, JW, Rowley, JD (1985) Philadelphia chromosome-negative chronic myelogenous leukemia: a morphological reassessment. Br J Haematol 60: 457–467
Raskind, WH, Fialkow, PJ (1987) The use of cell markers in the study of human hematopoietic neoplasia. Adv Cancer Res 49: 127
Rassool, F, Martiat, P, Taj, A, Klisak, I, Goldman, J (1990) Interstitial insertion in varying amounts of ABL-contaisning genetic material into chromosome 22 in Ph-negative CML. Leukemia 4: 273–277
Ribeiro, RC, Abromowitch, M, Raimondi, SC, Murphy, SB, Behm, F, Williams, DL (1987) Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 70: 948–953
Rodenhuis, S, Smets, LA, Slater, RM, Behrendt, H, Veerman, AJP (1985) Distinguishing the Philadelphia chromosome of acute lymphoblastic leukemia from its counterpart in chronic myeloid leukemia. New Engl J Med 313: 51–52
Rogers, J (1985) Oncogene chromosome breakpoints and Alu sequences. Nature 317: 559
Rowley, JD (1973) A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290–293
Scher, CD, Siegler, R (1975) Direct transformation of 3T3 cells by Abelson murine leukemia virus. Nature 253: 729–731
Shtalrid, M, Talpaz, M, Blick, M, Romero, P, Kantarjian, H, Taylor, K, Trujillo, J, Schachner, J, Gutterman, JU, Kurzrock, R (1988) Philadelphia-negative chronic myelogenous leukemia with bcr rearrangement: molecular analysis, clinical characteristics, and response to therapy. J Clin Oncol 6: 1569–1575
Shtivelman, E, Lifshitz, B, Gale, RP, Canaani, E (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 315: 550–554
Shtivelman, E, Lifshitz, B, Gale, RP, Roe, BA, Canaani, E (1986) Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47: 277–284
Sonta, S, Sandberg, AA (1977) Chromosomes and causation of human cancer and leukemia. XXIV. Unusual and complex Ph1 translocations and their clinical significance. Blood 50: 691–696
Stam, K, Heisterkamp, N, Reynolds, FH, Groffen, J (1987) Evidence that the phl gene encodes a 160 000-Dalton phosphoprotein with associated kinase activity. Mol Cell Biol 7: 1955–1960
Third International Workshop on Chromosomes in Leukemia (1981) Cancer Genet Cytogenet 4: 101–110
Timmons, MS, Witte, ON (1989) Structural characterization of the BCR gene product. Oncogene 4: 559–567
van derPlas, DC, Hermans, ABC, Soekarman, D, Smit, EME, deKlein, A, Smadja, N, Alimena, G, Goudsmit, R, Grosveld, G, Hagemeijer, A (1989) Cytogenetic and molecular analysis in Philadelphia negative CML. Blood 73: 1038–1044
vanEtten, RA, Jackson, P, Baltimore, D (1989) The mouse type IV c-abl gene product in a nuclear protein and activation of transforming ability is associated with cytoplasmic location. Cell 58: 669–678
Walker, LC, Ganesan, TS, Dhut, S, Gibbons, B, Lister, TA, Rothbard, J, Young, BD (1987) Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature 329: 851–853
Whang-Peng, J, Canellos, GP, Carbone, PP, Tjio, JH (1968) Clinical implications of cytogenetic variants in chronic myelocytic leukemia (CML). Blood 32: 755–766
Wiedemann, LM, Karhi, KK, Shivji, MKK, Rayter, SI, Pegram, SM, Dowden, G, Bevan, D, Will, A, Galton, DAG, Chan, LC (1988) The correlation of breakpoint cluster region rearrangements and p210 phl/abl expression with morphological analysis of Phnegative chronic myeloid leukemia and other myeloproliferative diseases. Blood 71: 349–355
Witte, ON, Goff, S, Rosenberg, N, Baltimore, D (1980) A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity. Proc Natl Acad Sci USA 77: 4993–4997
Young, JC, Witte, ON (1988) Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures. Mol Cell Biol 8: 4079–4087
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dobrovic, A., Peters, G.B. & Ford, J.H. Review: Molecular analysis of the Philadelphia chromosome. Chromosoma 100, 479–486 (1991). https://doi.org/10.1007/BF00352198
Issue Date:
DOI: https://doi.org/10.1007/BF00352198